SCHEMBL124787

SCHEMBL124787

CCCCOCN1C(=O)N(COCCCC)C2C1N(COCCCC)C(=O)N2COCCCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.42
TP53 P04637 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.39
GBA1 P04062 1/20 0.37
TSHR P16473 3/20 0.35
CYP3A4 P08684 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
HPGD P15428 1/20 0.34
USP2 O75604 2/20 0.34
POLB P06746 2/20 0.34
ALOX15 P16050 2/20 0.34
KDM4A O75164 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
ABL1 P00519 2/20 0.33
RIN1 Q13671 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
ALDH1A1 P00352 2/20 0.32
HSD17B10 Q99714 1/20 0.32
RARB P10826 1/20 0.32
CNOT7 Q9UIV1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12205532 0.94 L3MBTL1 (0.48) GAATP53L3MBTL1GBA1TSHR
SCHEMBL16284290 0.94 L3MBTL1 (0.48) GAATP53L3MBTL1GBA1TSHR
SCHEMBL14701295 0.93 TP53 (0.38) GAATP53L3MBTL1GBA1TSHR
SCHEMBL21414084 0.93 TP53 (0.38) GAATP53L3MBTL1GBA1TSHR
SCHEMBL20634310 0.91 L3MBTL1 (0.55) GAATP53L3MBTL1GBA1TSHR
SCHEMBL13380167 0.89 GAA (0.55) GAATP53L3MBTL1GBA1TSHR
SCHEMBL16610347 0.89 GAA (0.55) GAATP53L3MBTL1GBA1TSHR
SCHEMBL196871 0.88 L3MBTL1 (0.42) GAATP53L3MBTL1GBA1
SCHEMBL11372171 0.85 GBA1 (0.42) GAATP53L3MBTL1GBA1TSHR
SCHEMBL18804148 0.84 L3MBTL1 (0.39) GAATP53L3MBTL1GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 753 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006145-B2 Agrochemical formulations of microcapsules for compounds containing carboxamide groups FMC CORPORATION 2015-04-14 US claimed
US-20120157315-A1 AGROCHEMICAL FORMULATIONS OF MICROCAPSULES FOR COMPOUNDS CONTAINING CARBOXAMIDE GROUPS FMC CORPORATION 2012-06-21 US claimed
US-7008476-B2 Modified alginic acid of alginic acid derivatives and thermosetting anti-reflective compositions thereof AZ ELECTRONIC MATERIALS USA CORP. (US) 2006-03-07 US claimed
WO-2004111092-A1 MODIFIED ALGINIC ACID OR ALGINIC ACID DERIVATIVES AND THERMOSETTING ANTI-REFLECTIVE COMPOSITIONS THEREOF AZ ELECTRONIC MATERIALS USA CORP. (US) 2004-12-23 WO claimed
US-20040253532-A1 Modified alginic acid of alginic acid derivatives and thermosetting anti-reflective compositions thereof MERCK PATENT GMBH (DE) 2004-12-16 US claimed
US-6824951-B2 CROSSLINKING AGENT PREVENTS EXCESSIVE PHOTORESIST RESIN FLOW WHICH MAY RESULT IN A BENT OR COLLAPSED CONTACT HOLE PATTERN PROFILE; SEMICONDUCTORS HYNIX SEMICONDUCTOR INC. (KR) 2004-11-30 US claimed
US-6630281-B2 Forming positive pattern HYNIX SEMICONDUCTOR INC. (KR) 2003-10-07 US claimed
US-20020048723-A1 Photoresist composition for resist flow process HYNIX SEMICONDUCTOR INC. (KR) 2002-04-25 US claimed
US-20020031721-A1 Photoresist composition for top-surface imaging processes by silylation HYNIX SEMICONDUCTOR INC. (KR) 2002-03-14 US claimed
US-12607936-B2 Film-forming composition having a multiple bond NISSAN CHEMICAL CORPORATION (JP) 2026-04-21 US disclosed
US-12598958-B2 Wafer treatment method NISSAN CHEMICAL CORPORATION (JP) 2026-04-07 US disclosed
EP-4685840-A1 RELEASE AGENT COMPOSITION FOR PHOTOIRRADIATION RELEASE, LAYERED PRODUCT, AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE Nissan Chemical Corporation (JP) 2026-01-28 EP disclosed
EP-4678708-A1 ADHESIVE COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE Nissan Chemical Corporation (JP) 2026-01-14 EP disclosed
EP-4678709-A1 ADHESIVE COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE Nissan Chemical Corporation (JP) 2026-01-14 EP disclosed
US-20030022095-A1 Negative type radiation sensitive resin composition JSR CORPORATION (JP) 2003-01-30 US disclosed
US-6468714-B2 FINE PHOTORESIST PATTERNS JSR CORPORATION (JP) 2002-10-22 US disclosed
US-20020048723-A1 Photoresist composition for resist flow process HYNIX SEMICONDUCTOR INC. (KR) 2002-04-25 US disclosed
US-20020031721-A1 Photoresist composition for top-surface imaging processes by silylation HYNIX SEMICONDUCTOR INC. (KR) 2002-03-14 US disclosed
US-20010006758-A1 Negative radiation-sensitive resin composition JSR CORPORATION (JP) 2001-07-05 US disclosed
EP-1111465-A1 Negative radiation-sensitive resin composition JSR Corporation (JP) 2001-06-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12598958-B2 Wafer treatment method LIFR, FRK, ZAP70 GAA 79/4885TP53 1172/4885L3MBTL1 724/4885
US-12607936-B2 Film-forming composition having a multiple bond ETV1, ARF1, ETV6 GAA 4168/4885TP53 3855/4885L3MBTL1 646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.